spacer
home > epc > autumn 2002 > the 38th annual meeting of the drug information association, chicago
PUBLICATIONS
European Pharmaceutical Contractor

the 38th Annual Meeting of The Drug Information Association, Chicago

The Drug Information Association (DIA) held its 38th Annual Meeting in June. It was attended by about 7,000 delegates and included a large exhibition with approximately 475 exhibitors. The scale of the meeting, with sessions covering 29 interest areas, often made it difficult to choose which session to attend, so this report refers to those that I did attend, with apologies to all the others that I missed.

The first session included views from three business analysts on the CRO market. The overall trend is a return to financial stability and health within the market, exemplified by the (then) potential IPO of Inveresk. The CRO market was projected as US$9.3 billion for 2003, with the greatest increase expected in Phase II and IV clinical trials.

A recurring theme from all of the analysts was the importance of quality of service as a success factor for CROs. The relationship between the pharmaceutical sponsor and the CRO is often tested, as clinical research services are frequently purchased as a commodity, thereby removing the capacity to develop trust between the two parties. One speaker suggested that the length of the contracts used in these transactions is indicative of the lack of trust in the relationship.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Julia Lloyd-Parks, Senior Consultant at Technomark Consulting Services Ltd

Julia Lloyd-Parks joined Technomark as a Senior Consultant at the beginning of 2001.

She has worked within the pharmaceutical industry for 20 years, mostly in clinical research operations, with some time spent in project management and medical information fields. She has worked for several companies, including Syntex, Innovex and Novartis.

spacer
Julia Lloyd-Parks
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Introducing Signant Health [Formerly CRF Bracket] and the Industry’s Most Comprehensive Patient-Centric Suite for Clinical Research

Philadelphia and London – June 10, 2019: CRF Bracket, formed by the 2018 merger of CRF Health and Bracket, today launched as Signant Health (signanthealth.com). Uniting eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite, Signant makes it easier to participate in – and sites and study teams to run – clinical trials. This intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable sponsors and CROs to extend the reach of drug development, expand patient opportunities and improve data quality.
More info >>

White Papers

Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands

West Pharmaceutical Services, Inc.

The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >>

 
Industry Events

CPhI Worldwide

5-7 November 2019, Frankfurt, Germany

Join the World's Largest Pharma Event As it Celebrates its 30th Anniversary! Taking place from 5-7 November 2019 in Frankfurt, Germany, the event will bring together more than 45,000 visiting pharma professionals from around the globe and over 2,500 exhibiting pharma companies from every stage of the pharmaceutical supply chain - from ingredients and machinery to outsourcing services, packaging and more!
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement